BioCentury
ARTICLE | Company News

Progenics Phamaceuticals Inc. deal

May 16, 1994 7:00 AM UTC

Privately held Progenics and American Cyanamid Co. agreed to develop therapeutic agents using Progenics' HIV Universal Neutralizing Antibody (UNAb) technology with undisclosed American Cyanamid conjug...